Towards personalized antithrombotic management with drugs and devices across the cardiovascular spectrum
European Heart Journal

Abstract
Intravascular thrombus formation and embolization are among the most frequent events leading to a number of cardiovascular conditions with high morbidity and mortality. The underlying causes are stasis of the circulating blood, genetic and acquired coagulation disorders, and reduced antithrombotic or prothrombotic properties of the vascular wall (
Contributors

Thomas F Lüscher
Author
Royal Brompton and Harefield NHS Foundation Trust London , United Kingdom of Great Britain & Northern Ireland

Allan Davies
Author

Juerg H Beer
Author

Marco Valgimigli
Author

Christoph A Nienaber
Author
Harefield Hospital, Royal Brompton and Harefield NHS Foundation Trust London , United Kingdom of Great Britain & Northern Ireland

John A Camm
Author

Iris Baumgartner
Author

Hans-Christoph Diener
Author
Institute for Medical Informatics, Biometry and Epidemiology Essen , Germany

Stavros V Konstantinides
Author
University Medical Centre of the Johannes Gutenberg University Mainz , Germany



